PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
06-Nov-2019 Artios Pharma, MD Anderson and ShangPharma announce in-licensing agreement for DNA damage response inhibitor Artios Pharma Limited
06-Nov-2019 Urania Therapeutics closes a €3.5M initial seed round Urania Therapeutics
06-Nov-2019 Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2020 Financial Results on November 13, 2019 Elite Pharmaceuticals, Inc.
06-Nov-2019 Cells that could lead to new therapies: PromoCell now offers in vitro disease models PromoCell
06-Nov-2019 FLOURISH THROUGH THE MENOPAUSE Flourish
06-Nov-2019 Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO1 for Treatment of Acute Lymphoblastic Leukemia Autolus Therapeutics plc
06-Nov-2019 PureTech Affiliate Gelesis Presents Additional Data Highlighting Therapeutic Benefits of PlenityTM at ObesityWeek 2019 PureTech
06-Nov-2019 Biofrontera AG: Biofrontera Announces Conference Call on November 19, 2019 to Discuss Third Quarter 2019 Financial Results Biofrontera AG
06-Nov-2019 Heidelberg Pharma AG: Heidelberg Pharma Announces Participation at Various Conferences Heidelberg Pharma AG
06-Nov-2019 PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST NINE MONTHS OF 2019 PAION AG
06-Nov-2019 EVOTEC AND VIFOR PHARMA FORM JOINT VENTURE FOR EARLY DEVELOPMENT IN NEPHROLOGY Evotec SE
06-Nov-2019 15 Years of P-MEC China Driving Global Pharma Technology Forward in China P-MEC China
06-Nov-2019 15 Years of P-MEC China Driving Global Pharma Technology Forward in China P-MEC China
05-Nov-2019 Theravance Biopharma, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update Theravance Biopharma, Inc.
05-Nov-2019 Provention Bio Reports Third Quarter 2019 Financial Results Provention Bio, Inc.
05-Nov-2019 Jazz Pharmaceuticals Announces Third Quarter 2019 Financial Results Jazz Pharmaceuticals plc
05-Nov-2019 Rigel Announces Third Quarter 2019 Financial Results Rigel Pharmaceuticals, Inc.
05-Nov-2019 Portola Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update Portola Pharmaceuticals, Inc.®
05-Nov-2019 Masters Speciality Pharma Announces Launch of Neuropad® in Brazil for Detection of Diabetic Foot Syndrome Masters Speciality Pharma
05-Nov-2019 OB-002 Significantly Reduces Bone Metastasis in a Murine Model of Breast Cancer Orion Biotechnology Canada